Over 12,000 GI Cancer Cases Recorded in Gujarat as Late Diagnoses Pressure Healthcare Infrastructure
Summarized by AI; it may make mistakes. Check important info
Summarized by AI; it may make mistakes. Check important info
Gujarat is grappling with an escalating load of gastrointestinal (GI) cancers, recording between 12,000 and 15,000 new cases over the past year.
Digestive tract malignancies now account for 15% to 20% of the state's estimated 79,000 annual cancer cases, driven largely by high smokeless tobacco consumption, poor dietary habits, and sedentary lifestyles.
Oesophageal, colorectal, and gallbladder cancers form the bulk of these diagnoses across the state. Medical experts report that between 50% and 58% of patients present at locally advanced stages (Stage III or IV), primarily because early-stage symptoms remain vague and easily overlooked.
The surge in Gujarat mirrors a nationwide trend, where GI cancers account for nearly 3,00,000 of India's 15.7 lakh annual cancer cases.
National Oncology Leaders Convene in Ahmedabad for GIOS 2026
To address this growing medical burden, Sterling Hospitals, Ahmedabad, in association with the Gastrointestinal Oncology Society, held GIOS 2026, the third edition of the annual conference, on 19 September 2026. The two-day gathering brings together radiation, surgical, and medical oncologists, gastroenterologists, and clinical researchers from across India to standardise treatment protocols and refine multimodal therapies.
Deliberations at the conference focus on integrating advanced interventions into routine clinical practice, including:
- Robotic Surgery and Targeted Radiation: Deploying precision surgical platforms to improve resection margins while minimising recovery timelines.
- Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Evaluating specialised heated chemotherapy treatments for advanced peritoneal and gastrointestinal spread.
- Site-Specific Multidisciplinary Protocols: Tailoring care pathways to match the specific biological and anatomical profiles of individual digestive tract tumours.
Rising Incidence Among Younger Populations Sparks Clinical Alarm
Speaking at the event, Dr Pooja Nandwani Patel, Group Director of Radiation Oncology at Sterling Hospitals and Organising Secretary of GIOS 2026, highlighted a sharp shift in patient demographics.
"Food pipe cancer cases have increased considerably. In the last two decades, the number of cancer cases has risen by 25 percent, and we are seeing these cases rising among younger individuals as well," Dr Patel said. She warned that excess body weight triggers severe health complexities, emphasizing preventive measures such as regular exercise and balanced diets to mitigate risk factors.
Dr Patel added that the future of GI oncology relies heavily on site-specific expertise, noting that the right specialist within a dedicated multidisciplinary team dictates patient survival outcomes.
Bridging Research and Clinical Care Across India
The conference aims to align emerging scientific research directly with everyday clinical execution. Dr Reena Engineer, President of the Gastrointestinal Oncology Society (GIOS) and Chief of the GI Unit at Tata Memorial Hospital, Mumbai, stressed that the primary objective of GIOS 2026 is to bridge the gap between academic evidence and bedside practice across Indian hospitals.
